| IDDF | investigational drug data form |
|---|---|
| IDE | insulin-degrading enzyme; investigational device exemption |
| IDS | iduronate sulfatase; immune deficiency state; inhibitor of DNA synthesis; integrated delivery system... |
| IND | indomethacin; industrial medicine; investigational new drug |
| IDE | Investigational Device Exemption |
|---|---|
| IND | Investigational New Drug |
| IND | Investigational New Drug Application |
| investigational new drug | Status given an experimental drug after the FDA approves an application for testing it in people. (09 Oct 1997) |
|---|---|
| investigational new drug application | An application that must be submitted to a regulatory agency (the FDA in the united states) before a drug can be studied in humans. This application includes results of previous experiments; how, where, and by whom the new studies will be conducted; the chemical structure of the compound; how it is thought to work in the body; any toxic effects found in animal studies; and how the compound is manufactured. (12 Dec 1998) |
| drugs, investigational | Drugs which have received FDA approval for human testing but have yet to be approved for commercial marketing. This includes drugs used for treatment while they still are undergoing clinical trials (treatment ind). The main heading includes drugs under investigation in foreign countries. (12 Dec 1998) |
|---|
Synonyms : Investigational New Drug Applications
| investigational new drug |
A program that allows a drug developer to give physicians an experimental drug for people who have no other treatment options, once the drug has shown signs that it works and is safe.
출처: www.aegis.com/pubs/cria/2003/CR030902.html
|
|---|---|
| investigational new drug |
a drug allowed by the US Food and Drug Administration (FDA) to be used in clinical trials, but not approved for sale to the general public.
출처: www.luhs.org/health/topics/glossary/i.htm
|
| investigational new drug |
The pre-approval status of an experimental drug or biologic (eg vaccine) after the US Food and Drug Administration (FDA) agrees that it can be tested in people (generally done in order to collect sufficiently data for licensure.) "IND" often refers to the application to obtain this pre-approval status.
출처: www.sabin.org/vaccine_science_GlossaryH_K.htm
|
| investigational new drug |
Following clearance of an Investigational (preclinical) New Drug submission (IND), manufacturers may be authorized to supply a new drug to a qualified investigator(s) specifically for the purpose of conducting clinical evaluations to obtain data about the safety and efficacy of that drug. Information required for a preclinical new drug submission is outlined in section C.08.005 of the Food and Drug Regulations.
출처: www.hc-sc.gc.ca/vetdrugs-medsvet/glossary_of_terms...
|
| investigational new drug |
The status of an experimental drug after the Food and Drug Administration agrees that it can be tested in people.
출처: www.aidsinfobbs.org/letters/i.html
|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|